Evidence map›Paper›PMID 40705051›Full record

Trial reportInternational journal of biometeorology2025

Effects of kaempferol on weather-related pain: an open-label pilot study of subjective headache and other discomforts in pre-intervention and intervention periods in Japan.

Yasutaka Ikeda, Moe Yamamoto, Aina Gotoh-Katoh, Shoichiro Inoue, Jun Sato

Abstract readClinical Trial
In one paragraph

Trial report in International journal of biometeorology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yasutaka IkedaAdvanced Research Institute for Core Science, Otsuka Pharmaceutical Co., Ltd, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan.ORCID http://orcid.org/0000-0002-9128-279X
Moe YamamotoAdvanced Research Institute for Core Science, Otsuka Pharmaceutical Co., Ltd, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan.ORCID http://orcid.org/0009-0005-0105-3707
Aina Gotoh-KatohAdvanced Research Institute for Core Science, Otsuka Pharmaceutical Co., Ltd, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan.ORCID http://orcid.org/0000-0002-0979-2265
Shoichiro InoueAdvanced Research Institute for Core Science, Otsuka Pharmaceutical Co., Ltd, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan.ORCID http://orcid.org/0000-0001-8926-8027
Jun SatoDepartment of Pain Medicine, Aichi Medical University, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan. jsato0310@aichi-med-u.ac.jp.ORCID http://orcid.org/0000-0001-8840-5149

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse or fluctuating weather conditions can negatively affect health, causing symptoms known as weather-related pain. Although pharmacological treatments, including painkillers, are commonly used, they frequently provide only symptomatic relief and may cause side effects. Therefore, interest in non-pharmacological and dietary interventions is increasing. While inner ear sensitivity to barometric pressure fluctuations—activating the sympathetic nervous system—has traditionally been considered the main mechanism, we propose that reduced oxygen utilization due to peripheral hypoxia under low barometric pressure is also a key factor. Kaempferol, a dietary flavonoid, has been shown in prior studies to enhance oxygen utilization and promote parasympathetic nervous system dominance. We hypothesized that daily kaempferol intake would alleviate weather-related discomfort by improving oxygen use and autonomic balance. In this pilot study, 458 individuals with moderate weather-related symptoms took 10 mg of kaempferol daily for 4 weeks. Participants completed questionnaires before and after the intervention. Data from 387 individuals with over 80% adherence were analyzed. Results showed significant reductions in symptom frequency (e.g., headache: Cohen’s d = 0.61, p < 0.001), duration (rank-biserial correlation = 0.64, p < 0.001), and severity (Cohen’s d = 0.57, p < 0.001). By the end of the intervention, over 80% of participants reported symptom improvement. These findings suggest that kaempferol is a promising non-pharmacological strategy for managing weather-related physical and mental symptoms by targeting oxygen utilization and autonomic regulation. This trial is registered with the UMIN Clinical Trials Registry (UMIN000045066).

Indexed as

HeadacheKaempferolsPainWeatherAdultAgedFemaleHumansJapanMaleMiddle AgedPilot ProjectsYoung AdultkaempferolKaempferolsFlavonoidHypoxiaKaempferolOxygen utilizationParasympathetic nervous systemWeather-related pain

Identifiers

PMID40705051
PMCPMC12540546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.